{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:51:54Z","timestamp":1788277914090,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK114561"],"award-info":[{"award-number":["DK114561"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10620-021-07112-0","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T09:05:55Z","timestamp":1624439155000},"page":"2891-2898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients"],"prefix":"10.1007","volume":"67","author":[{"given":"Kayla","family":"Gelow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Chalasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3809-640X","authenticated-orcid":false,"given":"Craig","family":"Lammert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"issue":"6","key":"7112_CR1","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/mcg.0000000000000617","volume":"51","author":"JB Henson","year":"2017","unstructured":"Henson JB, Brown CL, Chow S-C, Muir AJ. Complementary and alternative medicine use in United States adults with liver disease. J Clin Gastroenterol. 2017;51:564\u2013570. https:\/\/doi.org\/10.1097\/mcg.0000000000000617.","journal-title":"J Clin Gastroenterol."},{"key":"7112_CR2","unstructured":"White CP, Hirsch G, Patel S, Adams F, Peltekian KM. Can J Gastroenterol. Published 2007. https:\/\/www.hindawi.com\/journals\/cjgh\/2007\/231636\/."},{"key":"7112_CR3","doi-asserted-by":"crossref","unstructured":"Del Prete A, Scalera A, Iadevaia MD, et al. Herbal Products: Benefits, Limits, and Applications in Chronic Liver Disease. Evidence-Based Complementary and Alternative Medicine. Published September 6, 2012. https:\/\/www.hindawi.com\/journals\/ecam\/2012\/837939\/. Accessed December 14, 2020.","DOI":"10.1155\/2012\/837939"},{"key":"7112_CR4","doi-asserted-by":"publisher","first-page":"175628482092755","DOI":"10.1177\/1756284820927550","volume":"13","author":"S Picardo","year":"2020","unstructured":"Picardo S, Altuwaijri M, Devlin SM, Seow CH. Complementary and alternative medications in the management of inflammatory bowel disease. Ther Adv Gastroenterol. 2020;13:175628482092755. https:\/\/doi.org\/10.1177\/1756284820927550.","journal-title":"Ther Adv Gastroenterol."},{"issue":"9","key":"7112_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/s0025-7753(04)74226-8","volume":"122","author":"M Bruguera","year":"2004","unstructured":"Bruguera M, Barrera JM, Ampurdan\u00e9s S, Forns X, S\u00e1nchez Tapias JM. Use of complementary and alternative medicine in patients with chronic hepatitis C. Medicina Clinica. 2004;122:334\u2013335. https:\/\/doi.org\/10.1016\/s0025-7753(04)74226-8.","journal-title":"Medicina Clinica."},{"key":"7112_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s12906-016-1379-3","volume":"16","author":"CY Liu","year":"2016","unstructured":"Liu CY, Chu JY, Chiang JH et al. utilization and prescription patterns of traditional Chinese medicine for patients with hepatitis C in Taiwan: a population-based study. BMC Complement Altern Med 2016;16:397.","journal-title":"BMC Complement Altern Med"},{"issue":"4","key":"7112_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1142\/S0192415X02000569","volume":"30","author":"ZC Yang","year":"2002","unstructured":"Yang ZC, Yang S-H, Yang S-S, Chen D-S. A hospital-based study on the use of alternative medicine in patients with chronic liver and gastrointestinal diseases. Am J Chin Med. 2002;30:637\u2013643. https:\/\/doi.org\/10.1142\/S0192415X02000569.","journal-title":"Am J Chin Med."},{"key":"7112_CR8","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1016\/j.cgh.2018.12.013","volume":"17","author":"C Lammert","year":"2019","unstructured":"Lammert C, Imler T, Teal E et al. Patients with chronic liver disease suggestive of nonalcoholic fatty liver disease may be at higher risk for drug-induced liver injury. Clin Gastroenterol Hepatol 2019;17:2814\u20132815.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7112_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/17425255.2017.1252749","volume":"13","author":"R Teschke","year":"2017","unstructured":"Teschke R, Danan G. Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue? Expert Opin Drug Metab Toxicol 2017;13:425\u2013438.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"7112_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s10620-019-05756-7","volume":"65","author":"K Mathur","year":"2020","unstructured":"Mathur K, Vuppalanchi V, Gelow K et al. Cannabidiol (CBD) consumption and perceived impact on extrahepatic symptoms in patients with autoimmune hepatitis. Dig Dis Sci 2020;65:322\u2013328. https:\/\/doi.org\/10.1007\/s10620-019-05756-7.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"7112_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/s1089-3261(03)00030-8","volume":"7","author":"TD Schiano","year":"2003","unstructured":"Schiano TD. Hepatotoxicity and complementary and alternative medicines. Clin Liver Dis. 2003;7:453\u2013473. https:\/\/doi.org\/10.1016\/s1089-3261(03)00030-8.","journal-title":"Clin Liver Dis."},{"key":"7112_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.14218\/JCTH.2019.00043","volume":"7","author":"CA Philips","year":"2019","unstructured":"Philips CA, Augustine P, Rajesh S et al. Complementary and alternative medicine-related drug-induced liver injury in Asia. J Clin Transl Hepatol. 2019;7:263\u2013274.","journal-title":"J Clin Transl Hepatol."},{"issue":"3","key":"7112_CR13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1053\/jhep.2001.27445","volume":"34","author":"L Seeff","year":"2001","unstructured":"Seeff L, Lindsay K, Bacon B, Kresina T, Hoofnagle J. Complementary and alternative medicine in chronic liver disease. Hepatology. 2001;34:595\u2013603. https:\/\/doi.org\/10.1053\/jhep.2001.27445.","journal-title":"Hepatology."},{"issue":"4","key":"7112_CR14","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/hep.30031","volume":"68","author":"LL Wong","year":"2018","unstructured":"Wong LL, Fisher HF, Stocken DD et al. The impact of autoimmune hepatitis and its treatment on health utility. Hepatology (Baltimore, Md). 2018;68:1487\u20131497. https:\/\/doi.org\/10.1002\/hep.30031.","journal-title":"Hepatology (Baltimore, Md)."},{"key":"7112_CR15","unstructured":"FDA. CFR - Code of Federal Regulations Title 21. www.accessdata.fda.gov. Published 2016. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?CFRPart=21."},{"key":"7112_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/MIB.0b013e31827f27c8","volume":"19","author":"M Koning","year":"2013","unstructured":"Koning M, Ailabouni R, Gearry RB et al. Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study. Inflamm Bowel Dis 2013;19:767\u2013778.","journal-title":"Inflamm Bowel Dis"},{"key":"7112_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s11926-013-0378-3","volume":"15","author":"CM Greco","year":"2013","unstructured":"Greco CM, Nakajima C, Manzi S. Updated review of complementary and alternative medicine treatments for systemic lupus erythematosus. Curr Rheumatol Rep 2013;15:378.","journal-title":"Curr Rheumatol Rep"},{"key":"7112_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/hep.28813","volume":"65","author":"VJ Navarro","year":"2017","unstructured":"Navarro VJ, Khan I, Bj\u00f6rnsson E et al. Liver injury from herbal and dietary supplements. Hepatology 2017;65:363\u2013373.","journal-title":"Hepatology"},{"key":"7112_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3945\/jn.110.133025","volume":"141","author":"RL Bailey","year":"2011","unstructured":"Bailey RL, Gahche JJ, Lentino CV et al. Dietary supplement use in the United States, 2003\u20132006. J Nutr. 2011;141:261\u2013266.","journal-title":"J Nutr."},{"issue":"3","key":"7112_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s10549-009-0315-3","volume":"117","author":"H Greenlee","year":"2009","unstructured":"Greenlee H, Kwan ML, Ergas IJ et al. Complementary and alternative therapy use before and after breast cancer diagnosis: the pathways study. Breast Cancer Res Treat. 2009;117:653\u2013665. https:\/\/doi.org\/10.1007\/s10549-009-0315-3.","journal-title":"Breast Cancer Res Treat."},{"key":"7112_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12906-020-02903-w","volume":"20","author":"EL Fj\u00e6r","year":"2020","unstructured":"Fj\u00e6r EL, Landet ER, McNamara CL et al. The use of complementary and alternative medicine (CAM) in Europe. BMC Complement Med Ther 2020;20:108.","journal-title":"BMC Complement Med Ther"},{"key":"7112_CR22","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1001\/jama.279.19.1548","volume":"279","author":"JA Astin","year":"1998","unstructured":"Astin JA. Why patients use alternative medicine: results of a national study. Jama 1998;279:1548\u20131553.","journal-title":"Jama"},{"key":"7112_CR23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3233\/NRE-141062","volume":"34","author":"C Medina-Perez","year":"2014","unstructured":"Medina-Perez C, De Souza-Teixeira F, Fernandez-Gonzalo R, De Paz-Fernandez JA. Effects of a resistance training program and subsequent detraining on muscle strength and muscle power in multiple sclerosis patients. NeuroRehabilitation 2014;34:523\u2013530.","journal-title":"NeuroRehabilitation"},{"issue":"11","key":"7112_CR24","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1097\/mib.0000000000001221","volume":"23","author":"GG Konijeti","year":"2017","unstructured":"Konijeti GG, Kim N, Lewis JD et al. Efficacy of the autoimmune protocol diet for inflammatory bowel disease. Inflamm Bowel Dis. 2017;23:2054\u20132060. https:\/\/doi.org\/10.1097\/mib.0000000000001221.","journal-title":"Inflamm Bowel Dis."},{"issue":"4","key":"7112_CR25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/1534735413485816","volume":"12","author":"J Finnegan-John","year":"2013","unstructured":"Finnegan-John J, Molassiotis A, Richardson A, Ream E. A systematic review of complementary and alternative medicine interventions for the management of cancer-related fatigue. Integr Cancer Ther. 2013;12:276\u2013290. https:\/\/doi.org\/10.1177\/1534735413485816.","journal-title":"Integr Cancer Ther."},{"issue":"1","key":"7112_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.7453\/gahmj.2015.104","volume":"5","author":"N Ghildayal","year":"2016","unstructured":"Ghildayal N, Jo Johnson P, Evans RL, Jo Kreitzer M. Complementary and alternative medicine use in the US adult low back pain population. Glob Adv Health Med. 2016;5:69\u201378. https:\/\/doi.org\/10.7453\/gahmj.2015.104.","journal-title":"Glob Adv Health Med."},{"issue":"1","key":"7112_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cger.2007.08.002","volume":"24","author":"NS Gooneratne","year":"2008","unstructured":"Gooneratne NS. Complementary and alternative medicine for sleep disturbances in older adults. Clin Geriatr Med. 2008;24:121\u2013138. https:\/\/doi.org\/10.1016\/j.cger.2007.08.002.","journal-title":"Clin Geriatr Med."},{"key":"7112_CR28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/hep.23317","volume":"51","author":"C Lammert","year":"2010","unstructured":"Lammert C, Bjornsson E, Niklasson A et al. Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events. Hepatology 2010;51:615\u2013620.","journal-title":"Hepatology"},{"key":"7112_CR29","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/hep.22272","volume":"47","author":"C Lammert","year":"2008","unstructured":"Lammert C, Einarsson S, Saha C et al. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals. Hepatology 2008;47:2003\u20132009.","journal-title":"Hepatology"},{"key":"7112_CR30","unstructured":"WHO. Guidelines on Good Agricultural and collection practices (GACP) for medicinal plantas. Vol 1. Geneve: World Health Organization Publications; 2013."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07112-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-07112-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07112-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T19:22:58Z","timestamp":1656357778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-07112-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["7112"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-07112-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,23]]},"assertion":[{"value":"15 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}